FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068105441> ?p ?o ?g. }

• W2068105441 endingPage "1038" @default.
• W2068105441 startingPage "1038" @default.
• W2068105441 abstract "A busy clinic is not the best setting within which to explain the nuances of oral triptan therapy, and even writing the same directions on 1 prescription after another rapidly loses whatever charms the act once may have possessed. This month's “tool” is a patient information sheet that some clinicians hopefully will find useful. The “triptans” are a family of drugs that were developed to treat acute migraine headache. Your doctor has prescribed for you 1 of the oral triptans: Imitrex (sumatriptan), Amerge (naratriptan), Zomig (zolmitriptan), Maxalt (rizatriptan), Axert (almotriptan), Frova (frovatriptan), or Relpax (eletriptan). Alternatively, he/she may have prescribed 1 of the 2 triptans marketed as nasal sprays: Imitrex nasal spray or Zomig nasal spray. Although all of the oral and intranasal triptans initially were investigated for the treatment of migraine headache of moderate to severe intensity and were superior to placebo in those pivotal trials, they appear to be more consistently effective when used to treat migraine earlier in the attack, when the headache is still mild to moderate. Ideally, the oral or intranasal triptans should be used as follows. Take 1 tablet (or administer 1 spray) for early/mild headache. This dose may be repeated after 2 hours. Do not use more than 2 doses within a 24-hour period, and do not use the triptans more than 2 days/week on a chronic basis. Frova and Amerge have a slower onset of action and longer biologic half-life in the body than the other triptans, and it is probably best to use them particularly early in an attack. The intranasal triptans, Imitrex nasal spray and Zomig nasal spray, tend to have a faster onset of action than the orally administered triptans, and some patients find that they are more effective than their oral counterparts in attempting to treat headaches than have progressed to a higher level of pain intensity. Zomig and Maxalt are sold in “melt” formulations as well as in tablet form; while the “melt” formulation may be more convenient (no liquid is required to wash them down) and may be preferred by patients who have migraine-associated nausea, there is no evidence to suggest that they work faster than the tablet formulations. Potential side effects of the triptans include nausea; jaw, neck, or chest tightness, pressure or squeezing; rapid heart rate; fatigue; numbness-tingling (especially involving the face); or a burning sensation over the skin. While these and other side effects are not uncommon, the triptans are a very safe class of medications when used appropriately by the patients for whom they are indicated. Interestingly, side effects seem to be less likely to occur when the triptan is taken early in the migraine attack. The triptans are not effective for all migraine patients and will not stop every headache even in those patients who do benefit from the drugs. Furthermore, if your response to the triptan you have been prescribed is less than desired, it may make sense to move on and try another. Contraindications to the use of the triptans include coronary artery disease, a history of stroke, uncontrolled high blood pressure, and co-administration of certain other medications. Check with your physician regarding the last, and confirm that the medications you are taking are safe to use with the triptans." @default.
• W2068105441 created "2016-06-24" @default.
• W2068105441 creator A5010632613 @default.
• W2068105441 date "2006-05-24" @default.
• W2068105441 modified "2023-10-17" @default.
• W2068105441 title "Oral Triptan Therapy" @default.
• W2068105441 doi "https://doi.org/10.1111/j.1526-4610.2006.00480.x" @default.
• W2068105441 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16732854" @default.
• W2068105441 hasPublicationYear "2006" @default.
• W2068105441 type Work @default.
• W2068105441 sameAs 2068105441 @default.
• W2068105441 citedByCount "1" @default.
• W2068105441 countsByYear W20681054412021 @default.
• W2068105441 crossrefType "journal-article" @default.
• W2068105441 hasAuthorship W2068105441A5010632613 @default.
• W2068105441 hasBestOaLocation W20681054411 @default.
• W2068105441 hasConcept C126322002 @default.
• W2068105441 hasConcept C170493617 @default.
• W2068105441 hasConcept C177713679 @default.
• W2068105441 hasConcept C2777030092 @default.
• W2068105441 hasConcept C2777119127 @default.
• W2068105441 hasConcept C2778541695 @default.
• W2068105441 hasConcept C2778871607 @default.
• W2068105441 hasConcept C2778938600 @default.
• W2068105441 hasConcept C2779085531 @default.
• W2068105441 hasConcept C2780564907 @default.
• W2068105441 hasConcept C2780973058 @default.
• W2068105441 hasConcept C42219234 @default.
• W2068105441 hasConcept C46821324 @default.
• W2068105441 hasConcept C71924100 @default.
• W2068105441 hasConcept C85663871 @default.
• W2068105441 hasConcept C98274493 @default.
• W2068105441 hasConceptScore W2068105441C126322002 @default.
• W2068105441 hasConceptScore W2068105441C170493617 @default.
• W2068105441 hasConceptScore W2068105441C177713679 @default.
• W2068105441 hasConceptScore W2068105441C2777030092 @default.
• W2068105441 hasConceptScore W2068105441C2777119127 @default.
• W2068105441 hasConceptScore W2068105441C2778541695 @default.
• W2068105441 hasConceptScore W2068105441C2778871607 @default.
• W2068105441 hasConceptScore W2068105441C2778938600 @default.
• W2068105441 hasConceptScore W2068105441C2779085531 @default.
• W2068105441 hasConceptScore W2068105441C2780564907 @default.
• W2068105441 hasConceptScore W2068105441C2780973058 @default.
• W2068105441 hasConceptScore W2068105441C42219234 @default.
• W2068105441 hasConceptScore W2068105441C46821324 @default.
• W2068105441 hasConceptScore W2068105441C71924100 @default.
• W2068105441 hasConceptScore W2068105441C85663871 @default.
• W2068105441 hasConceptScore W2068105441C98274493 @default.
• W2068105441 hasIssue "6" @default.
• W2068105441 hasLocation W20681054411 @default.
• W2068105441 hasLocation W20681054412 @default.
• W2068105441 hasOpenAccess W2068105441 @default.
• W2068105441 hasPrimaryLocation W20681054411 @default.
• W2068105441 hasRelatedWork W1989968180 @default.
• W2068105441 hasRelatedWork W2011778887 @default.
• W2068105441 hasRelatedWork W2049914468 @default.
• W2068105441 hasRelatedWork W2077723818 @default.
• W2068105441 hasRelatedWork W2078342884 @default.
• W2068105441 hasRelatedWork W2114122105 @default.
• W2068105441 hasRelatedWork W2139040608 @default.
• W2068105441 hasRelatedWork W2170714231 @default.
• W2068105441 hasRelatedWork W2432284598 @default.
• W2068105441 hasRelatedWork W2529500657 @default.
• W2068105441 hasVolume "46" @default.
• W2068105441 isParatext "false" @default.
• W2068105441 isRetracted "false" @default.
• W2068105441 magId "2068105441" @default.
• W2068105441 workType "article" @default.